Abstract
The new direct-acting antivirals (DAAs) for chronic hepatitis C (CHC) are highly effective, despite the short duration of treatment, and very tolerable [...].
Grants and funding
AIRC partially financed project number IG 2020-ID 24858 of the P.I. Erica Villa; The University of Padua, Department of Medicine-DIMED has provided funds for scientific research with the DOR project number 2023-2327032 of the P.I. Liliana Chemello.